Company Filing History:
Years Active: 2004-2016
Title: The Innovative Contributions of Diane Levitan
Introduction
Diane Levitan is a notable inventor based in Tenafly, NJ (US), recognized for her significant contributions to cancer treatment research. With a total of four patents to her name, she has made strides in utilizing biomarkers for monitoring cancer therapies.
Latest Patents
Diane's latest patents focus on the use of IL-8 as a biomarker in cancer treatment. One of her patents discusses the IL-8 level as a determinant of a cancer's responsiveness to treatment. This application includes methods for using IL-8 to assess tumor size during the course of treatment with anti-cancer agents, such as ERK inhibitors. Another patent emphasizes the role of IL-8 in monitoring cancer treatment with specific ERK inhibitors, further showcasing her innovative approach to improving cancer care.
Career Highlights
Throughout her career, Diane has worked with prominent organizations, including Merck Sharp & Dohme Corporation and Columbia University. Her experience in these institutions has allowed her to develop and refine her research in the field of oncology.
Collaborations
Diane has collaborated with various professionals in her field, including Ahmed Abdi Samatar and Brian Long. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Diane Levitan's work in cancer treatment through the use of IL-8 as a biomarker highlights her innovative spirit and dedication to improving patient outcomes. Her contributions continue to influence the field of oncology and inspire future research.